1-1 of 1
confounding by indication
Close
Sort by
Journal Articles

Response: Confounding by indication is unlikely to explain the higher inhibitor incidence in boys treated with a recombinant FVIII product

Clinical Trials & Observations
Thierry Calvez, Hervé Chambost, Patrick Lutz, Chantal Rothschild, Jenny Goudemand
Journal: Blood
Blood (2015) 125 (24): 3817–3819.
https://doi.org/10.1182/blood-2015-02-622167
Published: 2015
Includes: Supplemental data